To the best of our knowledge, this is the first report of a SLE-related cytopenia induced by MAS successfully treated anifrolumab and it could help to broaden the spectrum of the potential clinical scenarios for anifrolumab effectiveness.
Systemic lupus erythematosus-related macrophage activation syndrome inducing severe cytopenia successfully treated with anifrolumab: a case report / Chiara, E., Gasparotto, M., Malandrino, D., Biancalana, E., Uban, M.L., Silvestri, E., Emmi, G.. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - ELETTRONICO. - 43:(2025), pp. 0-0. [10.55563/clinexprheumatol/uumehz]
Systemic lupus erythematosus-related macrophage activation syndrome inducing severe cytopenia successfully treated with anifrolumab: a case report
Chiara, Emanuele;Malandrino, Danilo;Biancalana, Edoardo;Silvestri, Elena;Emmi, Giacomo
2025
Abstract
To the best of our knowledge, this is the first report of a SLE-related cytopenia induced by MAS successfully treated anifrolumab and it could help to broaden the spectrum of the potential clinical scenarios for anifrolumab effectiveness.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
article (11).pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
288.82 kB
Formato
Adobe PDF
|
288.82 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
